Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

    This grant allows organizations with specific NIH grants to apply for a change of recipient status, called Successor-in-Interest; approval is not guaranteed.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)

    This grant allows certain NIH grant recipients to request a change to the recipient organization with no guarantee of approval, seeking prior approval as described in the NIH Grants Policy Statement.

    HHS-NIH11Due Jul 12, 2027

    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)

    NIH offers funding for expanding existing projects or programs under specific criteria through Competing Revisions to NIH single project research grants and cooperative agreements without requiring clinical trials.

    HHS-NIH11Due Nov 24, 2026

    Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

    Funding available for NIH grant applications responding to presidentially declared disasters or public health emergencies through Emergency Notices of Special Interest.

    HHS-NIH11Due Apr 18, 2027

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted

    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

    NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.

    HHS-NIH11Due Feb 16, 2027$275,000